FDA Inspection
Nesher Pharmaceuticals (USA) LLCNesher Pharmaceuticals (USA) LLC – FDA Inspection, Feb 3, 2017
Record Details
This FDA Inspection record concerns Nesher Pharmaceuticals (USA) LLC, with an inspection on February 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 813a6884-247d-4603-94fc-aacccb0162de
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002432
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Nesher Pharmaceuticals (USA) LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 7, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 7, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nesher Pharmaceuticals (USA) LLC
- FDA Inspection 1151305 - 2021-08-12
- FDA Inspection 1095659 - 2019-05-31
- FDA Inspection 925349 - 2015-05-07
- FDA Inspection 855762 - 2013-11-07
- FDA Inspection 811438 - 2012-12-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.